MedPath

COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

Completed
Conditions
Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
Registration Number
NCT04524520
Lead Sponsor
Western Sussex Hospitals NHS Trust
Brief Summary

A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths.

The burden on global critical care has been considerable. As of 24th April there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input.

This study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. Recovery from a novel disease requires documenting and the study reports physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews are being conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
194
Inclusion Criteria
  1. Adults ≥18 years admitted to ICU with SARS-CoV-2 and survived
  2. Relatives or friends and professionals involved in the care of these patients.
Exclusion Criteria
  1. Patients <18 years;
  2. Patients with a negative test for SARS-CoV-2 or patients not tested due to absence of symptoms;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health Related Quality of lifeat 1 year

Short Form Survey on health related quality of life (SF-36). Scores can range from 0 to 100 and a higher score indicates better outcome.

Psychologicalat 1 year

Post-traumatic stress disorder (PTSD) Trauma Screening (TSQ). A screening tool with 10 items. If 6 items are endorsed then the outcome is 'positive' for PTSD.

Physicalthrough study completion , an average of 1 year

1- minute Sit to Stand, Grip strength

Secondary Outcome Measures
NameTimeMethod
risk stratificationthrough study completion and average of 1 year

critical care stay hospital stay (number of days)

Trial Locations

Locations (1)

Dr Luke Hodgson

🇬🇧

Worthing, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath